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Objectives. The aim of this study was to elucidate the progres-
sion of intramural hemorrhage complicated by reperfusion with
the use of myocardial contrast echocardiography.
Background. Although hemorrhagic infarction is known to
occur in ischemia followed by reperfusion, its onset and sequence
have not been well characterized.
Methods. In 20 anesthetized dogs, 3-h occlusion of the left
circumflex coronary artery was followed by reperfusion. The area
at risk during coronary occlusion was ;25%. Myocardial contrast
echocardiogram was examined, and the time-intensity curves for
both ischemic and nonischemic areas were obtained at baseline, at
3 min after reperfusion and then at 15-min intervals until 90 min
after reperfusion. The wall thickness of both areas was also
measured.
Results. Gross hemorrhage in the reperfused areas was ob-
served in five dogs (Group H) but not in seven dogs (Group NH).
All wall segments were opacified at 3 min after reperfusion in both
groups. However, the contrast defect spread significantly with
time after reperfusion in Group H but not in Group NH (18.7 6
3.4% and 3.3 6 1.8%, respectively, at 90 min after reperfusion p <
0.005). The wall of the risk area at 90 min after reperfusion had
thickened to 1.3 times baseline thickness in Group H but was
unchanged in Group NH. The other eight dogs were excluded from
study because of fatal arrhythmias or the existence of collateral
circulation during coronary occlusion.
Conclusions. Both progression of the contrast defect area on
myocardial contrast echocardiography and a gradual thickening
of the wall with reperfusion are characteristic of hemorrhagic
infarction.
(J Am Coll Cardiol 1997;30:585–91)
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Reperfusion in the early stages of myocardial infarction (MI) is
an indispensable part of therapy directed to relieving the
oxygen deficits of viable cardiac myocytes in ischemic areas.
However, reperfusion of an artery supplying an infarct area
may also cause irreversible damage to viable myocytes in some
cases. This phenomenon is called reperfusion injury (1–11).
Hemorrhagic MI, which retards the healing process after
infarction, is also a type of reperfusion injury (12). Hemor-
rhagic MI occurs after prolonged ischemia followed by reper-
fusion in experimental models (1,12–17) and even in 20% of
clinical patients (1). However, its clinical significance has not
been determined because its onset and progression of exten-
sion cannot be diagnosed.
Radionuclide examination, which allows a nonreperfused
bed to be identified accurately, is not suitable for detecting
infarct extension within a few hours in a reperfused bed. For
this reason, myocardial contrast echocardiography (MCE) is a
preferable method for directly and repeatedly visualizing an
area of a reperfused vascular bed (18–21). MCE demonstrates
the area with microvasculature intact. More precisely, the
opacified area identified by MCE represents the functional
territory of the coronary artery, without regard for occluded
branches, presence of collateral vessels or form of complex
bifurcation (18–23). Moreover, wall motion and thickening can
be analyzed simultaneously by MCE. We studied the progres-
sion of hemorrhagic MI in dogs with prolonged coronary
occlusion followed by reperfusion, examining sequential
changes in abnormal wall thickening and the contrast-opacified
areas, as well as the areas of hemorrhage in postmortem
specimens.
Methods
Animal preparation. Twenty mongrel dogs weighing 16 6
3 kg (mean 6 SD) were anesthetized with intravenous sodium
pentobarbital (30 mg/kg body weight intravenously, Abbott
Laboratories) after premedication with ketamine hydrochlo-
ride (5 mg/kg intramuscularly, Sankyo Co., Tokyo, Japan). The
study conformed to the “Position of the American Heart
Association on Research Animal Use” adopted November 11,
1984 by the American Heart Association. The dogs were
intubated, and ventilated through use of a respirator pump
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(model Mark 7, Bird). Additional anesthesia was administered
during the experiment as needed. A 7F catheter was placed in
the descending thoracic aorta by way of the right femoral
artery for recording of systemic blood pressure and measure-
ment of blood gases. A similar catheter was placed in the right
femoral vein for administration of fluids and drugs as needed.
A 6F catheter with a side hole was placed in the left coronary
sinus of Valsalva to inject a contrast agent for MCE.
The dogs were then placed in the right lateral decubitus
position and their chest was opened along the fourth or fifth
intercostal space. The pericardium was incised and used as a
cradle for the exposed heart. A microtipped pressure trans-
ducer (model SPC-350, Millar) was inserted into the left
ventricular cavity by way of the left ventricular apex. The
proximal left anterior descending coronary artery (LCx) was
dissected free from surrounding tissues, and an ultrasound flow
probe (model 4RS, Transonic Systems Inc.) was placed around
it to monitor the epicardial coronary blood flow (CBF). A
polyethylene capillary tube placed proximal to the flow probe
at the LCx was used to produce coronary occlusion. An initial
bolus injection of heparin (50 U/kg) administered intrave-
nously after insertion of these catheters was followed every
hour by supplemental injections of half the bolus amount to
prevent clotting of the catheter side holes.
Contrast agent preparation. A sonicator (model 250,
Branson) with a 3-mm diameter horn was used to generate
microbubbles. Ten milliliters of 5% human albumin (Green
Cross, Osaka, Japan) was sonicated for 30 s in an outer tube of
a 20-ml syringe. The power of the sonicator was 20 W and the
frequency 20 kHz. After 10 s of elapsed time to avoid
contamination from relatively large microbubbles, 2 ml of the
contrast solution was withdrawn to a syringe and 1 ml was
injected manually as a bolus with a speed of 1 ml/s. This
method produced a stable echocardiographic contrast agent
containing microbubbles 11 6 12 mm (median 5 mm) in
diameter and 3.9 3 105/ml in density, which were measured by
Coulter counter ZM (Coulter Corp.).
MCE. The echocardiographic system used was a phased
array system (SSH-60A, Toshiba, Tokyo, Japan) with a 3.5-
MHz transducer. Image registration was set to provide a
short-axis view at the midpapillary muscle level. The trans-
ducer was placed directly on the epicardial surface of the heart
such that the posterior wall was perpendicular to the ultra-
sound beam. Newly developed asynergy of the posterior wall
was examined by transient occlusion of the LCx. Gain settings
were optimized initially and held constant throughout the
experiment. Sonicated albumin microbubbles were injected
into the left coronary sinus of Valsalva during echocardio-
graphic recording. The respirator was kept off until the myo-
cardial opacification disappeared in order to fix the heart
position in the echocardiographic image. The images were
recorded on S-VHS videotape with use of a high fidelity video
recorder (model AG-7300, Panasonic, Osaka, Japan).
An off-line image analysis system (Color Cardiology Work
Station, Freeland Systems) was used to measure myocardial
videointensity by using a scale from black to white containing
256 shades of gray. Every end-diastolic frame from the time of
contrast injection until disappearance of myocardial opacifica-
tion was stored in this system. Regions of interest were placed
at the center of the ventricular septum as a control area, and at
the center of the posterior wall, which showed a contrast defect
during coronary occlusion. Both regions were rectangular with
dimensions of ;7 3 15 mm. From time-videointensity curves
from each region of interest, baseline and peak intensities were
measured. Peak intensity above baseline intensity is referred to
simply as peak intensity (PI) in this study.
As shown in the results, hemorrhage was found mainly on
the endocardial side of the ventricular wall. The posterior wall
was divided into three regions: endocardial, mid- and epicar-
dial layers, in each of which time-intensity curves were also
examined.
Echocardiographic measurement. The left ventricular end-
diastolic and end-systolic diameter and the wall thickness of
the anterior (or ventricular septum) and posterior walls of the
left ventricle were measured from M-mode echocardiograms
in the standard manner. Systolic thickening of the ventricular
wall was calculated as (Systolic wall thickness 2 Diastolic wall
thickness)/Diastolic wall thickness. We also calculated the wall
thickness ratio by dividing the end-diastolic thickness of the
posterior wall by that of the anterior or septal wall, to avoid the
influence of loading conditions. When the posterior wall is
thickened, this ratio is larger than the baseline value.
Experimental protocol. Baseline images from MCE were
obtained after confirming the absence of regional wall motion
abnormalities and the presence of good and homogeneous
opacification of the entire left ventricular wall. After adminis-
tration of lidocaine (1.5 mg/kg intravenously), the LCx was
occluded for 180 min. The ultrasound flow meter signal was
used to verify complete coronary occlusion during this period.
At 15 and 180 min after occlusion, MCE was performed to
examine the contrast defect area. When the contrast defect
area decreased during coronary occlusion, the dog was ex-
cluded from the study because of the existence of collateral
circulation. After 3 h of occlusion, lidocaine (1.5 mg/kg intra-
venously) was again administered, and the coronary occlusion
was released. MCE was performed just before release of the
occlusion, and at 3, 15, 30, 60 and 90 min after reperfusion. The
epicardial CBF of the LCx, aortic and left ventricular pressures
and heart rate were continuously monitored throughout the
experiment.
Abbreviations and Acronyms
CBF 5 coronary blood flow
LCx 5 left circumflex coronary artery
MCE 5 myocardial contrast
echocardiography or
echocardiogram
MI 5 myocardial infarction
PI 5 peak intensity above baseline
intensity
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Postmortem examination. The dog’s heart was excised and
cut in 1-cm thick slices along the short axis from the apex to the
base to examine for the presence of gross hemorrhage affecting
the ventricular wall. After fixation in 10% formalin, these slices
were photographed (35-mm film). The total myocardial areas
and hemorrhagic areas were calculated by digitization of these
photographs by using a commercially available Macintosh-
based computer system with the public domain NIH IMAGE
computer-assisted digital imaging processor. The hemorrhagic
area was expressed as a percent of total myocardial area. The
area attributable to the papillary muscles was not included.
The slices were stained with hematoxylin-eosin to micro-
scopically examine infarct areas. The area of MI was defined as
the region that included coagulation necrosis, contraction band
necrosis, wavy change of myofibrils, margination of neutro-
phils, pyknotic nuclei and edema of the interstitium, excluding
the area containing a mixture of normal and necrotic cells at
the border of the infarct area (24). Photomicrographs were
taken of the slices and traced for determination of infarct size.
Statistical analysis. Variables are presented as the mean
value 6 SD. Two-way repeated measures analysis of variance
with the Newman-Keuls test was applied for multiple compar-
ison under reperfusion conditions. The correlation was as-
sessed by linear regression analysis with use of a least-squares
method. A p value , 0.05 was considered significant.
Results
The entire protocol could be completed in 12 of the 20
dogs. Eight dogs did not complete the protocol because of the
existence of collateral circulation (n 5 3) or fatal arrhythmia
immediately after coronary occlusion or reperfusion (n 5 5).
Gross hemorrhage was observed in five dogs. The area of
hemorrhage ranged from 19.3% to 26.7% of the total myocar-
dial cross-sectional area. Figure 1 shows a representative
hemorrhagic case. In the remaining seven dogs, there was no
macroscopic hemorrhage, whereas some extravasation of
erythrocytes into the myocardial interstitium could be found
on histologic examination. In the results that follow, the
analyzed data are compared between the dogs with (Group H)
and without (Group NH) gross (macroscopic) hemorrhage.
Hemodynamic variables. There was no significant change
in heart rate, mean aortic pressure, left ventricular end-
diastolic pressure or peak positive first derivative of left
ventricular pressure after reperfusion in either group (Table
1). In both groups, epicardial CBF of the LCx increased to
240% of baseline value immediately after reperfusion, fol-
lowed by a gradual decline of flow to 50% to 70% of baseline
value. Thus, hemodynamic changes after reperfusion did not
differ between the two groups.
Systolic thickening and wall thickness. In Group NH,
systolic thickening of the posterior wall was 38.3 6 11.1% at
baseline and 6.2 6 9.0% at 3 min after reperfusion (Fig. 2A);
the systolic thickening recovered gradually and was 17.1 6
11.9% at 90 min after reperfusion. In Group H, systolic
thickening of the posterior wall was 33.1 6 5.6% at baseline
and 7.5 6 6.2% at 3 min after reperfusion. In the reperfusion
period, the systolic thickening of the posterior wall did not
recover but decreased, even at 90 min after reperfusion (2.5 6
2.1%, p 5 NS vs. 3 min after reperfusion). Differences of
recovery of systolic thickening at 30, 60 and 90 min after
reperfusion were all significantly different between the two
groups.
The wall thickness ratio of posterior to septal wall at
end-diastole, in Group NH, was 1.11 6 0.16 at baseline, 0.86 6
0.13 before reperfusion, 1.23 6 0.14 at 3 min after reperfusion
and 1.09 6 0.07 at 90 min after reperfusion (Fig. 2B). Changes
in the thickness ratio in Group H until 3 min after reperfusion
were the same as those in Group NH, which were 1.07 6 0.10
at baseline, 0.88 6 0.06 before reperfusion and 1.20 6 0.08 at
3 min after reperfusion. In Group H, the thickness ratio
increased gradually, becoming 1.32 6 0.14 at 90 min after
reperfusion (p , 0.005 vs. Group NH). It was a characteristic
of Group H that the reperfused wall became thicker (127%)
and did not show systolic thickening.
Time course of contrast defect size. The contrast defect
area was ;25% of the total cross-sectional area of the left
ventricular wall in both groups during coronary occlusion
(28.2 6 4.8% in Group H vs. 24.9 6 5.4% in Group NH).
Figure 3 illustrates the time course of contrast defect size after
reperfusion. Immediately after reperfusion, the area that had
been a contrast defect area during coronary occlusion was
Figure 1. Photograph of a horizontal section of the heart from a
representative dog in Group H. Gross hemorrhage occupies a large
part of the region of distribution of the LCx.
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clearly and definitely opacified in both groups. In the following
period, however, the contrast defect area showed reappear-
ance and spread in Group H. In this group, the contrast defect
size was 1.8 6 2.7% at 3 min after reperfusion, 10.2 6 4.5% at
30 min (p , 0.005 vs. 3 min after reperfusion) and 18.7 6 3.4%
at 90 min after reperfusion (p , 0.005). In Group NH, the
contrast defect area did not reappear significantly throughout
the reperfusion period and was 3.3 6 1.8% at 90 min after
reperfusion (p , 0.005 vs. the value in Group H).
Relation between areas of contrast defect, hemorrhage and
infarction. The size of the area of gross hemorrhage was not
correlated with infarct size. Intramural hemorrhage detected
by microscopy was observed only inside the infarct area. The
contrast defect area 90 min after reperfusion correlated with
the infarct area (r 5 0.712, p 5 0.014), but it was smaller than
the infarct area in all subjects (Fig. 4A). However, the contrast
defect area was almost the same as the area of hemorrhage,
showing good linear correlation (r 5 0.872, p 5 0.054; Fig. 4B).
Figure 5 shows a representative case from Group H. More-
over, the area of gross hemorrhage agreed approximately with
the area of contrast defect geometrically.
PI ratio of endocardial to epicardial layer within the
postischemic area. PI was almost the same between the
endocardial and the epicardial layers of the posterior wall in
the two groups before coronary occlusion; that is, the PI ratio
was almost 1.0 (Fig. 6). The PI ratio did not change at 3 min
after reperfusion in either group. However, in three of the five
dogs in Group H, the endocardial layer was not opacified at
15 min after reperfusion, and in another dog, the endocardial
layer became unopacified at 60 min after reperfusion. As a
result, the PI ratio of the endocardial to the epicardial layer
decreased with time in Group H, whereas the ratio was almost
constant in Group NH.
Discussion
Progressive wall thickening as an indicator of hemorrhagic
infarction. In the present study, systolic thickening decreased
and wall thickness increased at later phases of reperfusion in
five dog hearts with hemorrhagic MI. Earlier investigators (25)
demonstrated an increase in end-diastolic wall thickness dur-
ing reperfusion after brief coronary occlusion, and they sug-
gested that this change was related to transient increased
coronary blood volume secondary to a reactive hyperemic
response to reperfusion. This change was analogous to that in
our Group NH. Haendchen et al. (26,27) reported that the
ventricular wall became far thicker in a model of longer
coronary occlusion and suggested that the causes of this
thickening were myocardial edema, intracellular and intersti-
tial swelling, intramural hemorrhage, myocardial contracture
and extent of necrosis. This change may be analogous to that in
our Group H. In addition, our study indicated that the
temporal changes in wall thickness after reperfusion were quite
different between the two groups. In Group H, the walls
thickened in response to reactive hyperemia became progres-
sively thicker despite a lessening of reactive hyperemia,
whereas in Group NH the thickened wall returned to normal
thickness over time. We conjecture that the progressive thick-
ening of infarct areas after reperfusion is one of the most
important diagnostic signs of hemorrhage.
Development of contrast defect after reperfusion as an
indicator of hemorrhagic infarction. MCE demonstrates the
area of perfused myocardium (18,21,22) and showed that the
extent of ischemia during coronary occlusion was almost the same
in both Group H and Group NH. After reperfusion, the
contrast defect area at 3 min was somewhat smaller than that
at 15 min in both groups. Villanueva and co-workers (28)
Table 1. Hemodynamic Variables
Before
Occlusion
During Occlusion After Reperfusion
15 min 180 min 3 min 30 min 90 min
HR (beats/min)
Group H 149 6 15 150 6 15 151 6 12 141 6 8 143 6 10 141 6 12
Group NH 162 6 21 160 6 20 156 6 22 151 6 19 149 6 19 148 6 19
Mean AoP (mm Hg)
Group H 115 6 32 102 6 28 95 6 18 95 6 23 94 6 23 88 6 24
Group NH 97 6 9 94 6 15 90 6 20 78 6 16 85 6 18 87 6 17
LVEDP (mm Hg)
Group H 7 6 5 14 6 6 11 6 3 11 6 6 11 6 6 11 6 7
Group NH 5 6 3 8 6 6 6 6 4 8 6 4 7 6 4 7 6 4
Peak positive LV dP/dt (mm Hg/s)
Group H 2,036 6 349 1,612 6 487 1,496 6 314 1,340 6 343 1,400 6 346 1,300 6 380
Group NH 2,084 6 254 1,786 6 195 1,723 6 321 1,300 6 252 1,506 6 240 1,568 6 242
CBF of LCx (% of baseline)
Group H 100 . . . . . . 246 6 159 68 6 27* 51 6 27*
Group NH 100 . . . . . . 238 6 76 82 6 12* 69 6 16*
*p , 0.01 versus 3 min after reperfusion. AoP 5 aortic pressure; CBF 5 coronary blood flow; dP/dt 5 first derivative
of left ventricular pressure; Group H 5 dogs with hemorrhage; Group NH 5 dogs without hemorrhage; HR 5 heart rate;
LCx 5 left circumflex coronary artery; LV 5 left ventricular; LVEDP 5 left ventricular end-diastolic pressure; . . . 5 not
detected.
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indicated that the contrast defect size at phases earlier than
15 min after reperfusion was smaller than the infarct size as a
result of reactive hyperemia. Therefore, the existence of
reactive hyperemia in all of our cases suggested that there was
little microvascular disruption within the infarct area soon
after reperfusion.
The contrast defect area increased with time after 15 min
after reperfusion in Group H, whereas it was constant in
Group NH. Necropsy revealed that the area of hemorrhage
was almost the same as that of the contrast defect just before
the dogs were euthanized. Expansion of contrast defect area
may indicate progression of hemorrhage in reperfused areas.
We speculate that there was a slight microvascular disruption
soon after reperfusion and that capillaries either became
occluded secondary to thrombus or microvascular spasm or
were obstructed as a consequence of interstitial pressure
elevation due to hemorrhage. As a result, the contrast defect
area expanded gradually. Even in Group NH, which had no
evidence of gross hemorrhage, there was a small degree of
microvascular disruption with extravasation of erythrocytes
into the interstitium histologically. However, it was difficult to
identify these extravasations through observations of changes
in wall thickness and the time-videointensity curves of MCE.
Time course of hemorrhage inferred from contrast defect
after reperfusion. When does myocardial hemorrhage occur
and how does it expand with time? Some investigators (17,29)
have declared that the area of hemorrhage is smaller than that
of myocardial necrosis, and that this hemorrhage is always
within the necrotic area. Necrosis of myocytes would be
completed and microvascular damage would have progressed
during 3 h of coronary occlusion, and the injured capillaries
would subsequently be disrupted after reperfusion (24,30,31).
Cerra and co-workers (1) demonstrated that capillary disrup-
tion expanded transmurally during 180 min in a canine model.
Gracia-Dorado et al. (24) demonstrated that the hemorrhage
did not occur in a pig model subjected to 60 min of occlusion
followed by 30 min of reperfusion and reocclusion, whereas
definite hemorrhage was noted in pigs with prolonged reper-
fusion after 45 min of occlusion. In Group H, our study
demonstrated development of an abnormally thickened wall
detected at 30 to 60 min after reperfusion, indicating that
myocardial hemorrhage occurred during that period.
Figure 2. Line graphs comparing percent change in systolic wall
thickening at risk area (A) and wall thickness ratio (B) between Group
H and Group NH. In the period after reperfusion, systolic wall
thickening was increased in Group NH, whereas it was unchanged in
Group H. In both groups, wall thickness ratio at end-diastole was lower
during coronary artery occlusion than before occlusion. This ratio
recovered after reperfusion in Group NH, whereas it increased
significantly at 30 min after reperfusion in Group H. Wall thickness
ratio was significantly higher in Group H than in Group NH at 30, 60
and 90 min after reperfusion. *p , 0.05, #p , 0.01, §p , 0.005 versus
Group NH. ‡p , 0.005 versus 3 min after reperfusion.
Figure 3. Line graph comparing contrast defect size determined by
MCE in Group H and Group NH over time. In Group H, contrast
defect size increased significantly from 3 to 90 min after reperfusion.
There were significant differences between the two groups after 30 min
after reperfusion. †p , 0.05, ‡p , 0.005 versus 3 min after reperfusion.
§p , 0.005 versus Group NH. LV 5 left ventricle.
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No reflow and myocardial hemorrhage. Failure of recana-
lization of the microvasculature despite recanalization of
larger vessels is referred to as a no-reflow phenomenon (32). Ito
and co-workers (33) compared the findings of MCE with those
of coronary angiography after reperfusion in patients with
acute MI. They visually demonstrated the no-reflow phenom-
enon on MCE. Kloner (34) speculated that potential causes of
the observed no-reflow phenomenon included several micro-
scopic changes such as plugging of neutrophils or erythrocytes,
contracture of microvasculature, swelling of the myocardium,
endothelium damage and myocardial hemorrhage. It is difficult
to specify the causes from clinical findings. Our present study
demonstrated the significance of sequential measurements of
wall thickness and contrast defect area after reperfusion. Both
gradual thickening of the wall and extension of contrast defect
area may be helpful in distinguishing hemorrhage from plug-
ging of the microvasculature.
Limitations of the study. MCE has some limitations in
evaluating myocardial perfusion quantitatively. Although we
adjusted the gain settings of the equipment and the injection
volume and speed of microbubbles throughout the experiment,
these adjustments could not ensure that the density and size of
microbubbles would be identical among injections and sub-
jects. A large bubble mingling by chance with smaller ones will
bias the washout time of the contrast echo to be long. In
consideration of this possibility, we did not use the raw
absolute data of our study, but rather compared the PI
between the reperfused and remote areas. Fortunately, the
border between opacified and nonopacified areas was clear
and manual tracing of the border was easy. Tracings of the
definite border were reproducible, even manually (18,35,36).
The definition of hemorrhage may be critical to interpreta-
tion of results. We classified subjects with microscopic but
without gross hemorrhage as falling into the nonhemorrhage
group (Group NH). Microscopic hemorrhage is very common
in postischemic areas. The measurement of the area of hem-
orrhage is also critical. As discussed earlier, it would be difficult
to quantify the size of microscopic hemorrhage because of
patchy red cell extravasation and capillary degeneration, mak-
ing the border zone unclear. In the present study, we measured
the area of gross hemorrhage through the aid of photography,
with which the border zone was relatively clearly defined.
Clinical implications. This study indicates that hemor-
rhagic MI may be diagnosed in the presence of combined
Figure 5. Same dog as in Figure 1. MCE at 90 min after reperfusion.
A, Before injection of contrast agent. B, After injection. The extent
of contrast defect (arrows) is similar to the area of hemorrhage in
Figure 1.
Figure 6. Line graph comparing the PI ratio of endocardium to
epicardium on MCE between Group H and Group NH over time. In
Group H, the serial changes of this ratio decreased significantly after
reperfusion. There were significant differences between the two groups
after 15 min of reperfusion. ‡p , 0.005 versus 3 min after reperfusion.
§p , 0.005 versus Group NH.
Figure 4. A, Relation between infarct size deter-
mined by hematoxylin-eosin staining (x axis) and
echographic perfusion defect size (y axis) in the two
groups. B, Relation between macroscopic hemor-
rhage size (x axis) and the perfusion defect size on
MCE at 90 min after reperfusion (y axis) in Group H.
Dotted line 5 the line of identity; dashed curves 5
95% confidence limits of the regression line. LV 5
left ventricle.
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abnormal thickening of the reperfused region and extension of
the perfusion defect after recanalization. Unfortunately, there
is no method to diagnose hemorrhagic MI clinically at present,
although the complication is a common clinical occurrence.
With intravenous MCE (37–40), it is possible to observe
myocardial perfusion repeatedly and noninvasively even in
human studies, enabling the diagnosis of hemorrhagic MI after
reperfusion therapy. We believe that our findings will help to
reveal the mechanisms and prognosis of hemorrhagic MI.
We thank Joe Alexander, Jr., MD for valuable advice and careful checking of this
report.
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